Home / News / FAQ
FAQ

FAQ on SOBRsafe Inc.'s Q1 2025 Financial Performance and Technology

FaqStaq News - Just the FAQs • May 23, 2025
By FAQstaq Staff
Read Original Article →
FAQ on SOBRsafe Inc.'s Q1 2025 Financial Performance and Technology

Summary

SOBRsafe Inc. reported an 80.5% revenue growth and improved margins in Q1 2025, driven by increased software subscriptions and sales of its SOBRsure(TM) devices, alongside narrowing net losses and strategic leadership enhancements.

What was SOBRsafe Inc.’s revenue growth in Q1 2025?

SOBRsafe Inc. reported an 80.5% year-over-year revenue growth in Q1 2025, reaching $86.6K.

How did SOBRsafe Inc. improve its gross margin in Q1 2025?

The company improved its gross margin to 58.8% in Q1 2025, driven by increased software subscriptions and sales of SOBRsure(TM) devices.

What contributed to the narrowing of SOBRsafe Inc.’s net loss in Q1 2025?

The net loss narrowed to $1.9 million from $2.5 million a year ago, primarily due to increased software subscriptions and SOBRsure(TM) device sales.

What percentage of SOBRsafe Inc.’s total revenue comes from software subscriptions?

Software subscription revenue accounted for 53.8% of SOBRsafe Inc.’s total revenue in Q1 2025.

How many SOBRsure(TM) devices were deployed by SOBRsafe Inc. in Q1 2025?

The company deployed 148 SOBRsure(TM) devices in Q1 2025, marking a 41% increase from year-end.

What is SOBRsafe(TM) technology?

SOBRsafe(TM) is a next-generation alcohol detection technology that uses advanced transdermal (touch-based) technology to detect and report the presence of alcohol through a user’s skin, requiring no breath, blood, or urine samples.

Where can I learn more about SOBRsafe Inc.?

For more information about SOBRsafe Inc., visit their website at www.SOBRsafe.com or check the latest news and updates in the company’s newsroom at https://ibn.fm/SOBR.

What markets does SOBRsafe technology serve?

SOBRsafe technology serves the behavioral health, judicial, and consumer markets, offering solutions for point-of-care screening and continuous monitoring.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 112005